UniProt ID | IRF2_HUMAN | |
---|---|---|
UniProt AC | P14316 | |
Protein Name | Interferon regulatory factor 2 | |
Gene Name | IRF2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 349 | |
Subcellular Localization | Nucleus. | |
Protein Description | Specifically binds to the upstream regulatory region of type I IFN and IFN-inducible MHC class I genes (the interferon consensus sequence (ICS)) and represses those genes. Also acts as an activator for several genes including H4 and IL7. Constitutively binds to the ISRE promoter to activate IL7. Involved in cell cycle regulation through binding the site II (HiNF-M) promoter region of H4 and activating transcription during cell growth. Antagonizes IRF1 transcriptional activation.. | |
Protein Sequence | MPVERMRMRPWLEEQINSNTIPGLKWLNKEKKIFQIPWMHAARHGWDVEKDAPLFRNWAIHTGKHQPGVDKPDPKTWKANFRCAMNSLPDIEEVKDKSIKKGNNAFRVYRMLPLSERPSKKGKKPKTEKEDKVKHIKQEPVESSLGLSNGVSDLSPEYAVLTSTIKNEVDSTVNIIVVGQSHLDSNIENQEIVTNPPDICQVVEVTTESDEQPVSMSELYPLQISPVSSYAESETTDSVPSDEESAEGRPHWRKRNIEGKQYLSNMGTRGSYLLPGMASFVTSNKPDLQVTIKEESNPVPYNSSWPPFQDLPLSSSMTPASSSSRPDRETRASVIKKTSDITQARVKSC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
18 | Phosphorylation | WLEEQINSNTIPGLK HHHHHHHCCCCCCCH | 36.66 | 25022875 | |
29 | Acetylation | PGLKWLNKEKKIFQI CCCHHHCCCCEEEEC | 69.60 | 12738767 | |
31 | Acetylation | LKWLNKEKKIFQIPW CHHHCCCCEEEECCH | 53.42 | 12738767 | |
32 | Acetylation | KWLNKEKKIFQIPWM HHHCCCCEEEECCHH | 50.25 | 12738767 | |
75 | Acetylation | GVDKPDPKTWKANFR CCCCCCHHHHHHHHH | 74.52 | 12738767 | |
78 | Sumoylation | KPDPKTWKANFRCAM CCCHHHHHHHHHHHH | 38.39 | - | |
78 | Ubiquitination | KPDPKTWKANFRCAM CCCHHHHHHHHHHHH | 38.39 | 12738767 | |
78 | Sumoylation | KPDPKTWKANFRCAM CCCHHHHHHHHHHHH | 38.39 | 12738767 | |
78 | Acetylation | KPDPKTWKANFRCAM CCCHHHHHHHHHHHH | 38.39 | 12738767 | |
98 | Phosphorylation | IEEVKDKSIKKGNNA HHHHHHHCCCCCCCC | 50.18 | 28509920 | |
115 | Phosphorylation | VYRMLPLSERPSKKG EEEECCCCCCCCCCC | 29.62 | 28348404 | |
119 | Phosphorylation | LPLSERPSKKGKKPK CCCCCCCCCCCCCCC | 53.90 | 23186163 | |
137 | Sumoylation | EDKVKHIKQEPVESS HHHHHHHHHCCCCHH | 48.61 | - | |
137 | Sumoylation | EDKVKHIKQEPVESS HHHHHHHHHCCCCHH | 48.61 | 28112733 | |
143 | Phosphorylation | IKQEPVESSLGLSNG HHHCCCCHHHCCCCC | 30.97 | 30108239 | |
144 | Phosphorylation | KQEPVESSLGLSNGV HHCCCCHHHCCCCCC | 16.98 | 30108239 | |
148 | Phosphorylation | VESSLGLSNGVSDLS CCHHHCCCCCCCCCC | 29.73 | 26657352 | |
152 | Phosphorylation | LGLSNGVSDLSPEYA HCCCCCCCCCCHHHH | 33.94 | 30108239 | |
155 | Phosphorylation | SNGVSDLSPEYAVLT CCCCCCCCHHHHHHH | 22.22 | 29523821 | |
158 | Phosphorylation | VSDLSPEYAVLTSTI CCCCCHHHHHHHHHH | 12.85 | 29523821 | |
162 | Phosphorylation | SPEYAVLTSTIKNEV CHHHHHHHHHHHHCC | 19.75 | 29523821 | |
163 | Phosphorylation | PEYAVLTSTIKNEVD HHHHHHHHHHHHCCC | 24.79 | 19413330 | |
164 | Phosphorylation | EYAVLTSTIKNEVDS HHHHHHHHHHHCCCC | 30.64 | 19413330 | |
166 | Sumoylation | AVLTSTIKNEVDSTV HHHHHHHHHCCCCCE | 47.33 | - | |
166 | Sumoylation | AVLTSTIKNEVDSTV HHHHHHHHHCCCCCE | 47.33 | 28112733 | |
225 | Phosphorylation | ELYPLQISPVSSYAE HCCCEEECCCCHHCC | 13.29 | 28112733 | |
228 | Phosphorylation | PLQISPVSSYAESET CEEECCCCHHCCCCC | 22.48 | 26074081 | |
229 | Phosphorylation | LQISPVSSYAESETT EEECCCCHHCCCCCC | 28.70 | 26074081 | |
230 | Phosphorylation | QISPVSSYAESETTD EECCCCHHCCCCCCC | 13.59 | 26074081 | |
241 | Phosphorylation | ETTDSVPSDEESAEG CCCCCCCCCHHHCCC | 56.34 | 24275569 | |
245 | Phosphorylation | SVPSDEESAEGRPHW CCCCCHHHCCCCCCH | 29.58 | 24275569 | |
260 | Sumoylation | RKRNIEGKQYLSNMG HHCCCCCHHHHHHCC | 23.99 | - | |
260 | Sumoylation | RKRNIEGKQYLSNMG HHCCCCCHHHHHHCC | 23.99 | - | |
271 | Phosphorylation | SNMGTRGSYLLPGMA HHCCCCCCCCCCCHH | 14.87 | 27067055 | |
272 | Phosphorylation | NMGTRGSYLLPGMAS HCCCCCCCCCCCHHH | 18.32 | 27067055 | |
293 | Sumoylation | PDLQVTIKEESNPVP CCCEEEEEECCCCCC | 46.17 | - | |
293 | Sumoylation | PDLQVTIKEESNPVP CCCEEEEEECCCCCC | 46.17 | - | |
333 | Phosphorylation | PDRETRASVIKKTSD CCHHHHHHHHHHHHH | 22.53 | 28348404 | |
338 | Phosphorylation | RASVIKKTSDITQAR HHHHHHHHHHCHHHH | 26.99 | 23401153 | |
339 | Phosphorylation | ASVIKKTSDITQARV HHHHHHHHHCHHHHH | 35.58 | 27732954 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IRF2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Interferon regulatory factor-2 regulates cell growth through itsacetylation."; Masumi A., Yamakawa Y., Fukazawa H., Ozato K., Komuro K.; J. Biol. Chem. 278:25401-25407(2003). Cited for: ACETYLATION AT LYS-75 AND LYS-78, INTERACTION WITH CREBBP, FUNCTION,MASS SPECTROMETRY, AND MUTAGENESIS OF LYS-75 AND LYS-78. | |
Sumoylation | |
Reference | PubMed |
"Regulation of IRF2 transcriptional activity by its sumoylation."; Han K.-J., Jiang L., Shu H.-B.; Biochem. Biophys. Res. Commun. 372:772-778(2008). Cited for: SUMOYLATION AT LYS-137; LYS-166 AND LYS-293, FUNCTION, AND MUTAGENESISOF LYS-137; LYS-166 AND LYS-293. |